PTSD risk associated with a functional DRD2 polymorphism in heroin-dependent cases and controls is limited to amphetamine-dependent individuals
Elliot C Nelson, Andrew C Heath, Michael T Lynskey, Arpana Agrawal, Anjali K Henders, Lisa M Bowdler, Alexandre A Todorov, Pamela AF Madden, Elizabeth Moore, Louisa Degenhardt, Nicholas G Martin, Grant W Montgomery
Addiction Biology | WILEY | Published : 2014
Awarded by National Institute on Drug Abuse
This work was supported by the National Institute on Drug Abuse (R01 DA017305 to E.C.N.); support was also received from the National Drug and Alcohol Research Centre and the Australian National Health and Medical Research Council (to L. D.). The authors would like to thank the NDARC research team (Fiona Shand, Elizabeth Conroy, Michelle Torok, Caitlin McCue, Cherie Kam and Greg French), Anthony Caracella for his work in sample receipt and preparation, Megan Campbell for project coordination, and Sara Smith and Leanne Wallace for their efforts in sample genotyping.